FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and is applied in surgery, dermatology, obstetrics, gynaecology and otorhinolaryngology for treating pyoinflammatory processes of soft tissues and mucous membranes. An agent contains the following components, mass fractions: as a base - enterosgel (60.0-80.0), as therapeutic components, an antiseptic - 0.05% chlorhexidine bigluconate (20.0-40.0), and a regeneration stimulator - methyluracil (2.0-4.0).
EFFECT: invention provides the therapeutic agent possessing antiseptic, wound-healing and sorption functions.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2601897C1 |
LOCAL PHARMACEUTICAL ANTIBACTERIAL COMPOSITION OF ACTIVE BIOMETALLIC COMPLEXES | 2011 |
|
RU2489147C2 |
WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2013 |
|
RU2542376C1 |
COMPOSITION FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS (VARIANTS) | 1997 |
|
RU2150936C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2013 |
|
RU2542373C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2603490C1 |
MEANS FOR THE TREATMENT OF PURULENT-INFLAMMATORY PROCESSES OF SOFT TISSUES AND MUCOUS MEMBRANES. | 2021 |
|
RU2774440C1 |
PURULENT WOUND HEALING TECHNIQUE | 2008 |
|
RU2409372C2 |
Authors
Dates
2012-03-20—Published
2010-12-03—Filed